US 9125821
Nanodrug targeting protein geranylgeranylation
granted A61KA61K31/216A61K31/40
Quick answer
US patent 9125821 (Nanodrug targeting protein geranylgeranylation) held by The Regents of the University of California expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/216, A61K31/40, A61K31/402, A61K31/4418